Science Advances · 2019 · 13 citations · 38 references
Life SciencesMolecular BiologyMolecular GeneticsGene ExpressionMolecular NeuroscienceNeurogeneticsNeural DevelopmentDifferential Promoter UsagePmp22 Deletion
in neurofibroma initiation and/or maintenance. Targeting disruption of RUNX/CBFB interaction might provide a novel therapy for patients with neurofibroma.
38
ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia
Stephen G. Landt, Georgi K. Marinov, Anshul Kundaje et al. · Genome Research · 2012 · 2.2K citations · Full text
Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh Marcus et al. · New England Journal of Medicine · 2016 · 665 citations · Full text
Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment
Yuan Zhu, Pritam Ghosh, Patrick Charnay et al. · Science · 2002 · 636 citations · Full text
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
Joseph D. Growney, Hirokazu Shigematsu, Zhe Li et al. · Blood · 2005 · 453 citations · Full text
Life Sciences, Genetics, Hematology +14